Initial CDK 4/6 Inhibitor Plus Endocrine Therapy Versus Initial Chemotherapy in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer
Clinical trial NCT06344793 · COMPLETED
Trial details
- NCT number
- NCT06344793
- Sponsor
- Fudan University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-05-20
- Primary completion
- 2024-10-01
- Enrollment
- 608
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.